Amgen, the biotech giant based in Thousand Oaks, donated $2 million to the Lazarex Cancer Foundation for a program that aims to increase access for minorities to clinical oncology trials. The donation will support the Lazarex Foundation’s Improving Patient Access to Cancer Clinical Trials (IMPACT) program, which conducts outreach and helps pay expenses for diverse…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
